DGAP-News: SYGNIS Pharma AG: EDISON values SYGNIS at 37.5 million euros DGAP-News: SYGNIS Pharma AG / Key word(s): Study
SYGNIS Pharma AG: EDISON values SYGNIS at 37.5 million euros
10.07.2013 / 16:17
---------------------------------------------------------------------
Press Release
EDISON values SYGNIS at 37.5 million euros
- This valuation amply exceeds the current market quotation and ascribes
the shares a potential growth rate of more than 50%.
- EDISON base their analysis on three of SYGNIS' current products,
including QualiPhi, which was li
(0)
(0)